JENLOGA Drug Patent Profile
✉ Email this page to a colleague
When do Jenloga patents expire, and what generic alternatives are available?
Jenloga is a drug marketed by Concordia Pharms Inc and is included in one NDA.
The generic ingredient in JENLOGA is clonidine hydrochloride. There are twenty-two drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the clonidine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Jenloga
A generic version of JENLOGA was approved as clonidine hydrochloride by ACTAVIS ELIZABETH on December 16th, 1986.
Summary for JENLOGA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 135 |
Patent Applications: | 1,898 |
Formulation / Manufacturing: | see details |
DailyMed Link: | JENLOGA at DailyMed |
![JENLOGA drug patent expirations Drug patent expirations by year for JENLOGA](/p/graph/s/t/JENLOGA-patent-expirations.png)
Anatomical Therapeutic Chemical (ATC) Classes for JENLOGA
US Patents and Regulatory Information for JENLOGA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Concordia Pharms Inc | JENLOGA | clonidine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022331-001 | Sep 30, 2009 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Concordia Pharms Inc | JENLOGA | clonidine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022331-002 | May 25, 2010 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for JENLOGA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Concordia Pharms Inc | JENLOGA | clonidine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022331-001 | Sep 30, 2009 | ⤷ Try a Trial | ⤷ Try a Trial |
Concordia Pharms Inc | JENLOGA | clonidine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022331-002 | May 25, 2010 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for JENLOGA
See the table below for patents covering JENLOGA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 5259396 | ⤷ Try a Trial | |
Germany | 69534283 | ⤷ Try a Trial | |
World Intellectual Property Organization (WIPO) | 9622768 | ⤷ Try a Trial | |
Spain | 2245782 | ⤷ Try a Trial | |
Australia | 707843 | ⤷ Try a Trial | |
European Patent Office | 0805677 | PREPARATION DE CLONIDINE A LIBERATION PROLONGEE (EXTENDED RELEASE CLONIDINE FORMULATION) | ⤷ Try a Trial |
Canada | 2211325 | PREPARATION DE CLONIDINE A LIBERATION PROLONGEE (EXTENDED RELEASE CLONIDINE FORMULATION) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |